Articles tagged with Personalized Medicine
Researchers developed a platform that allows engineered biosensor bacteria to safely pass through the gastrointestinal tract in animal models. The platform enables real-time monitoring of gut health and can be used to diagnose and monitor various diseases, including inflammatory bowel disease. It has the potential to revolutionize pati...
Researchers aim to create machine learning tools that can analyze and quantify shape information from images, enabling more accurate diagnoses and improving patient care. A new family of deep neural networks, called DSNNs, will be developed to tackle AI's blind spot in image analysis.
A new open-source software, NMSM Pipeline, enables clinicians and engineers to create personalized computer models of patient movement to optimize treatment designs. The software uses physics-based models to predict and optimize functional outcomes for patients with various mobility impairments.
A Cochrane review reveals that organizational interventions can reduce the use of physical restraints in care home residents by 14%, without increasing falls or fall-related injuries. Supportive managers play a crucial role in implementing these interventions, which improve knowledge, skills, and strategies among frontline staff.
Researchers have uncovered almost 500 genes linked to diet, shedding light on genetic basis of food preferences. The findings suggest a potential for using genetics to develop precision nutrition strategies tailored to individual tastes.
A new UCLA Health study analyzed genetic data from 36,000 patients to identify disease risks and healthcare utilization among ancestrally diverse groups in the Los Angeles region. The research found substantial differences in diagnoses, hospital utilization, and genetic disease rates across clusters linked by shared genetic ancestry.
A large-scale study found that exercise programs for dialysis patients lead to significant improvements in physical fitness, quality of life, and reduced hospital stays. Personalized exercise plans showed low costs per training unit, making them a viable option for standard healthcare coverage.
Researchers discovered that Nerofe and Doxorubicin can downregulate KRAS signaling, leading to enhanced apoptosis in colorectal cancer cells. The combination also activates the immune system against tumor cells, increasing immunostimulatory cytokines and recruiting NK cells and M1 macrophages.
The global nuclear medicine initiative addresses the need for standardized educational curriculums to train physicians in nuclear theranostics procedures. The report highlights the rapid evolution of theranostic radiopharmaceuticals and emphasizes the importance of continuing medical education to maintain expertise.
The PanDrugs2 programme analyzes alterations in tumour genes, relates them to existing available drugs, and reports on the most suitable ones. It handles data on over 4,600 genes and 14,600 chemical compounds, generating information on around 74,000 associations between drugs and genes.
A multinational study identified immune resilience as a critical factor influencing life span, HIV/AIDS, flu, sepsis mortality, recurrent skin cancer, and COVID-19 mortality. Individuals with optimal levels of immune resilience were more likely to resist infections and recover from inflammatory stressors.
A powerful new stem cell technique has enabled large-scale studies of the relationship between human genetics and biology, accelerating research and potential personalized treatments.
A team of researchers discovered a process that helps breast cancer cells implant themselves in certain places in the body, leading to poorer prognosis. Overproduction of NNMT is key to metastasis, producing excessive collagen that enables cancer cells to survive and adapt.
ComboMATCH initiates patient enrollment to test new cancer drug combinations guided by tumor biology, exploring precision medicine and targeting proteins that control cancer growth. The project aims to identify beneficial therapies for patients with rare malignancies and/or rare molecular abnormalities.
A Vanderbilt study found that enhanced treatment support doubles the odds of quitting among fast nicotine metabolizers. Providing personalized coaching on nicotine replacement therapy reduces the abstinence disparity with slow metabolizers.
The PARIS Test, a CLIA-certified drug sensitivity assay, uses patient-derived tumor organoids to screen an array of drugs and develop personalized treatment reports. Ibrutinib, a BTK inhibitor approved only for certain leukemias and lymphomas, was identified as the optimal treatment for a patient with ovarian cancer.
The National Institutes of Health is enrolling 10,000 participants in a landmark precision nutrition study. The study aims to develop algorithms predicting how individuals respond to different foods and diets based on genetic, lifestyle, and environmental factors.
Researchers developed a biobank of head and neck cancer organoids to validate biomarkers and predict treatment responses. The study found that organoid responses matched patient outcomes, suggesting potential for personalized therapies.
A UNLV study found a significant correlation between 10 specific types of gut bacteria and the likelihood of developing Alzheimer's disease, with certain bacteria identified as protective or risk factors. The findings suggest that an imbalance of gut microbiota may play a role in the disorder's development.
A study by UMC Utrecht shows that corona patients can measure their blood oxygen levels at home using a pulse oximeter, feeling safe and experiencing more control. This method does not increase GP visits or hospitalization but contributes to relieving caregivers and keeping healthcare affordable.
Physicians are urging primary care teams to use data-driven approaches to prevent and mitigate climate-related health issues, dubbed "precision ecologic medicine". This approach combines patient-specific data with climate-related information to predict and support vulnerable patients.
A new study published in JCI Insight identified a second target for treating depression using transcranial magnetic stimulation (TMS), showing that each target alleviates a different set of symptoms. Patients who had high baseline depression and anxiety measures responded better to standard TMS treatment, while those with low baseline ...
NUTRITION 2023 will cover the latest developments in nutrition science, with over 1,800 original research studies submitted for presentation. The event brings together nutritional professionals from around the globe to discuss key topics such as sustainable diets and their impact on health.
Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.
A comprehensive care plan has been published to prevent preeclampsia, a leading cause of pregnancy-related death in the US. The plan provides specific recommendations for both expecting parents and clinicians, including daily low-dose aspirin, surveillance, and behavioral strategies.
A new 'enhanced primary care' model has been found to be effective in reducing blood pressure and hemoglobin A1c levels among patients with severe mental illness. The study, conducted at UNC WakeBrook, showed significant improvements in screening for people with severe mental illness compared to usual primary care.
A team of Lithuanian scientists created a VR-based rehabilitation system to help patients recover from stroke. The system uses sensors to track the patient's movements and provides real-time feedback to improve motor function, balance, and coordination.
Researchers at TUM have developed a method to create mini-hearts in Petri dishes using stem cells. The resulting organoids mimic the earliest stages of human heart development and can be used to investigate congenital heart defects, potentially leading to new treatment methods.
The Human Brain Project has achieved significant scientific breakthroughs, including world-leading 3D brain atlases and personalized medicine based on computational modeling. The project's legacy will leave a lasting impact on the research community.
Researchers have created a new tool, EN-TEx, to analyze genetic mutations and predict disease risk. The catalog of allele-specific variants provides rich data for accurate personal genomics, enabling scientists to study the effects of genetic mutations in tissues that are difficult to obtain without surgery.
A real-world analysis found that high-risk Americans who fail to reach guideline-recommended LDL-C levels experience a 44% higher rate of cardiovascular events. The study, presented at the AMCP Conference, used data from over 300 million Americans and compared those who met and maintained recommended targets with those who did not.
A systematic review of 156 trials found that physical exercise improved motor symptoms and quality of life in people with Parkinson's Disease. Most types of structured exercise, including dance, water-based exercise, and endurance training, showed clinically meaningful benefits.
A recent study found that the side effects of treating brain diseases with antisense oligonucleotides are related to altered calcium balance. By modulating calcium levels, researchers hope to reduce neurotoxicity and improve treatment outcomes for various neurological diseases.
The HALP score, a novel immune-nutritional marker, has been linked to prognostic ability in different cancer types. It integrates indicators of immune status and nutritional status, showing promise as a cost-effective biomarker.
A recent study found that promoting physical activity and behavioral support can help smokers reduce their smoking in the short-term, but delivering lasting benefits is challenging. The research, which recruited over 900 smokers, discovered that engaging with motivational support had some initial benefits, but only a small percentage o...
A study published in the American Journal of Critical Care found that a single trained observer serving as a checklist prompter can accurately assess whether multidisciplinary rounds addressed key elements of the ABCDEF bundle. This approach enables customized, shorter checklists to streamline workflows and improve patient care.
The ESMO Targeted Anticancer Therapies Congress 2023 features presentations on drug discovery and development for various targets, precision medicine, and early clinical trial methodology. Keynote lectures highlight novel insights in mutational signatures and epigenetic therapies.
Researchers at the University of Missouri have designed a soft and breathable material that can be worn on the skin without causing discomfort. The material, made from liquid-metal elastomer composite, has integrated antibacterial and antiviral properties to prevent the formation of harmful pathogens.
Dr. Ruth Ann Marrie has made significant contributions to multiple sclerosis research, including the discovery of comorbidities' impact on MS evolution and development of personalized medicine strategies. Her work aims to improve quality of life by stopping and preventing MS through early intervention and targeted treatments.
Researchers from the University of Tsukuba found that web-based interventions are effective in promoting weight loss in people with overweight and obesity. The most effective components include social support, self-monitoring, behavioral goal setting, and personalized information.
Researchers investigate how lung cancers evade the immune system to develop more effective immunotherapy treatments. The study aims to uncover a new way lung cancers disguise themselves from the immune system, potentially leading to improved treatment outcomes.
The updated guidelines aim to increase impact and improve research integrity by defining and measuring outcomes in clinical trials. The new extensions include nine outcome-specific items that should be defined in all trial protocols and 17 additional items to address in published reports, ensuring transparency and relevance for patients.
Researchers identified two molecularly distinct subsets of long COVID symptoms with opposing gene expression patterns during acute COVID-19. These findings suggest multiple independent processes leading to different long COVID symptoms, which are already present during the acute infection.
Researchers at the University of Missouri are developing a wearable heart monitor using a breathable material with antibacterial and antiviral properties. The device will track heart health via dual signals, providing continuous monitoring for early detection of heart disease.
Researchers have discovered that a specific mutation in the misfolding protein causing Parkinson's disease can also protect against multiple system atrophy (MSA), another fatal neurodegenerative disorder. The findings provide a promising lead for developing targeted treatments using personalized medicine approaches.
Patients who received treatment in Spanish were twice as likely to be abstinent at six months compared to those treated in English. Receipt of nicotine replacement therapy increased abstinence rates for all patients, regardless of language preference.
Research emphasizes the importance of ethnically diverse prostate cancer genomics data and accessible genetic testing. Variations in genomic landscape of prostate cancer were observed in Chinese men compared to Western cohorts, with lower mutation rates in driver genes such as TP53 and PTEN.
The ESMO Asia Congress 2022 will focus on the latest scientific and clinical advances in oncology, with a special emphasis on the Asia-Pacific region. Media representatives can register for coverage through the official media registration form.
A new guideline aims to standardize human genomic sequencing research in Canada by establishing essential core consent elements. This will enable researchers to collect patient data in a consistent manner, ensuring transparency for participants and streamlining the review process.
ISB researchers found that the gut microbiome is responsible for variation in circulating blood metabolites across people. The study examined 930 blood metabolites and found that over 60% were associated with either host genetics or the gut microbiome.
Researchers from the University of Zurich have discovered why a stem cell transplant is effective in treating multiple sclerosis. The study found that memory T cells reappear immediately after the transplant and do not trigger an autoimmune reaction due to pre-damage caused by chemotherapy. This knowledge enables the body to gradually ...
The NCI-MATCH precision medicine cancer trial found a promising signal for the AKT inhibitor ipatasertib, meeting its primary endpoint with a 22% response rate in patients with rare AKT1 E17K tumor gene mutations. The study demonstrated clinically significant activity in patients, warranting additional studies.
Researchers found that male mice were three times more likely to survive E. coli infection due to sex-biased lipid metabolism, which may hold risks for males in today's high-calorie environment. The study identified a signaling pathway regulating lipids and growth hormone as potential therapeutic targets for fatty liver disease.
A meta-analysis by Goethe University Frankfurt found that individualized treatment combined with cognitive behavioral therapy (CBT) led to a significant increase in pain relief. The study showed an 84% higher success rate compared to standard exercise therapies, making this approach the most effective.
A new AI model called CODE-AE can accurately predict the efficacy of novel drug compounds in humans, addressing a major challenge in drug discovery. The technique has been shown to improve accuracy and robustness over state-of-the-art methods, with potential applications in personalized medicine.
New research from the University of Kansas found that two common federal survey question sets are missing significant numbers of individuals with psychiatric disabilities and chronic health conditions. The study suggests that these gaps indicate undercounting of disability funds, services, and healthcare resources.
A national US kidney disease registry found that 60% of participants were unaware of their kidney function level, hindering clinical trial recruitment. The National Kidney Foundation Patient Network aims to address this issue through real-world data collection and patient-centered research.
Research institutes from Finland, Germany, Norway, Spain, and Sweden have launched the Federated European Genome-phenome Archive (Federated EGA) to improve data sharing across national borders. The new platform enables secure access to sensitive human data for research while respecting national data protection regulations.
Researchers are using in vitro skeletal muscle models to study Type 2 diabetes and its treatment. These models enable the exploration of disease characteristics and discovery of new medicines tailored to individual patients' muscles.
The DeFi trial shows targeting the Notch pathway with nirogacestat improves progression-free survival and reduces symptoms in patients with desmoid tumours. Patients reported a statistically significant benefit in reduced pain, symptom burden, and improved quality of life.